Details of the Drug

General Information of Drug (ID: DM1ARHT)

Drug Name
BYM338
Indication
Disease Entry ICD 11 Status REF
Inclusion body myositis 4A41.2 Phase 3 [1]
Acute myeloid leukaemia 2A60 Phase 2/3 [2]
Muscle atrophy FB32.Y Phase 2 [3]
Cross-matching ID
TTD ID
D0S5FF
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Activin receptor type IIA (ACVR2A) TTX2DRI AVR2A_HUMAN Inhibitor [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8086).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)